0001140361-20-003647.txt : 20200219 0001140361-20-003647.hdr.sgml : 20200219 20200219163105 ACCESSION NUMBER: 0001140361-20-003647 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200214 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freitag Gregory Gene CENTRAL INDEX KEY: 0001492710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 20630206 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD. CITY: ALACHUA STATE: FL ZIP: 32615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDS Biotechnology Corp CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 303A COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 303A COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: Edge Therapeutics, Inc. DATE OF NAME CHANGE: 20090911 4 1 form4.xml FORM 4 X0306 4 2020-02-14 0001472091 PDS Biotechnology Corp PDSB 0001492710 Freitag Gregory Gene C/O PDS BIOTECHNOLOGY CORPORATION 303A COLLEGE ROAD EAST PRINCETON NJ 08540 true Common Stock 2020-02-14 4 A 0 38400 1.3 A 40271 D Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on February 14, 2020. /s/ Gregory Gene Freitag 2020-02-19